Login to Your Account

Financings Roundup

Idenix Prices $70.3M Offering on Basis of Stock's Strength

By Marie Powers
Staff Writer

Thursday, November 17, 2011
Idenix Pharmaceuticals Inc. took advantage of the tailwind in its stock, which on Tuesday hit a 52-week high of $7.38, by pricing a public offering disclosed one day earlier.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription